Hans Koning

818 citations
15 papers · 680 indexed · h-index 9
Topics
Drug Transport and Resistance Mechanisms (7 papers)Pediatric Hepatobiliary Diseases and Treatments (3 papers)Porphyrin Metabolism and Disorders (2 papers)
Partner nations
NetherlandsCanadaItaly

In The Last Decade

Hans Koning

15 papers receiving 656 citations

Peers

Hans Koning
Comparison fields: 5 of 83
  • Oncology 511
  • Surgery 228
  • Pediatrics, Perinatology and Child Health 167
  • Molecular Biology 159
  • Epidemiology 107
Replace Giulia Ghibellini with:
Giulia Ghibellini United States
Zahra Tolou–Ghamari Iran
Antonín Libra Czechia
K. H. Holtermüller Germany
A. W. Mondorf Germany
Sandhya Manohar United States
Tom Moran Ireland
Ruijuan Sun China
Julia Chen United States
Haruki Mori Japan
Hans Koning relative to Giulia Ghibellini United States Giulia Ghibellini's profile →
Citations per field
00.5×1.5×2.2×
Giulia Ghibellini · 1×
Citations per year

Countries citing papers authored by Hans Koning

Since Specialization
Citations

This map shows the geographic impact of Hans Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Koning more than expected).

Fields of papers citing papers by Hans Koning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Koning. The network helps show where Hans Koning may publish in the future.

Co-authorship network of co-authors of Hans Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Koning. A scholar is included among the top collaborators of Hans Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Koning. Hans Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4
OPTIMAL VELOCITY PROFILES FOR VAULT
5
5 75
6 50
7 38
8 11
9 299
10 18
11 2
12 125
13 9
14 2
15 42

About Hans Koning

Hans Koning is a scholar working on Toxicology, Internal Medicine and Oncology, having authored 15 papers that have together received 680 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers) and Porphyrin Metabolism and Disorders (2 papers). The work is most often cited by research in Oncology (511 citations), Pharmacology (85 citations) and Pediatrics, Perinatology and Child Health (167 citations). Hans Koning has collaborated with scholars based in Netherlands, Canada and Italy. Frequent co-authors include Michael Müller, Han Moshage, Guido Hooiveld, Peter L. M. Jansen, Sarah J. Childs, Dirk K. F. Meijer, Han Roelofsen, Folkert Kuipers, R.J. Bosscher and Catalin M. Filipeanu. Their work appears in journals such as Blood, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026